Recent findings, including the discovery of risk genes involved in inflammation signaling, indicate that inflammation is critical for the onset and progression of Alzheimer's Disease. Regulatory T cells (Tregs) play an important neuroprotective role in suppressing microglia/macrophage-mediated inflammation, as well as modulating adaptive immune reactions. A progressive compromise in the immunomeulatory function of Tregs occurs through the course of Alzheimer's disease. Recovering the immunosuppressive capacity of Tregs may serve as a potential immunotherapy to treat Alzheimer's pathology.

Alireza Faridar, MD
Neurologist
Stanley H. Appel Department of Neurology
Nantz National Alzheimer Center
Houston Methodist

This event will be held in the Ernest H. Cockrell Boardroom (R211-311) & Online via MS Teams. In-person attendance is limited.